	Challenges in immunotherapy and targeted therapy era of advanced cutaneous melanoma: Toxicities, resistance, outcomes. Pathol Res Pract Fan Z, Mei Y, Liu K, Zhang Y, Shi L. PMID: 42462383 [PubMed - as supplied by publisher]
	Erratum: Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma. JCO Precis Oncol Ma VT, Zhou AY, Forati A, Hollnagel F, Patel JD, Burkey C, Steimle A, Sahasrabudhe DM, Mannino MC, Schehr JL, Birbrair A, Zhao SG, Lang JM, Victor AI. PMID: 42460914 [PubMed - in process]
	The gut-skin axis in melanoma: from microbial regulatory mechanisms to clinical translation for precision management. Front Microbiol Su X, Xiang Y, Zhao H, Li O, Zhang L, Guo B. PMID: 42459887 [PubMed]
	Case Report: Localized neutrophilic dermatosis at a split-skin donor site during PD-1 blockade: a unique immune-related adverse event. Front Immunol Moravenova V, Wilhelm R, Veeser J, Begaj K, Weidenthaler-Barth B, Grabbe S, Stege H, Wittmann M. PMID: 42459659 [PubMed - indexed for MEDLINE]
	PRAME immunohistochemistry demonstrates high diagnostic accuracy for distinguishing melanoma from nevi but no observed association with pT stage in cutaneous melanoma: a Vietnamese clinicopathological study. Diagn Pathol Tran GH, Truong DH, Nguyen LN, Thai TA, Luong KA. PMID: 42458521 [PubMed - as supplied by publisher]
	Correction: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801. Clin Transl Oncol Cerezuela-Fuentes P, Piñero-Madrona A, Muñoz-Couselo E, Manzano JL, Berciano-Guerrero MÁ, Majem M, Espinosa E, Soria A, Ayala de Miguel P, García Castaño A, Crespo G, Gutiérrez Sanz L, Aguado de la Rosa C, Fernández-Morales LA, Puértolas T, Fra Rodríguez J, Rodríguez de la Borbolla M, Bellido L, López Castro R, Navarro Pérez V, García Arroyo FR, Villa Guzmán JC, Campos Balea B, Hernández B, Martín Algarra S, Márquez-Rodas I. PMID: 42458140 [PubMed - as supplied by publisher]
	Impact of BRAF inhibitors on surgical outcomes in melanoma brain metastases: Evidence from a multicenter observational study. J Clin Neurosci Armocida D, Bianconi A, Carbone F, Leone A, D'Amico A, Pesce A, Cofano F, Fiaschi P, Salvati M, Zona G, Denaro L, Frati A, Spetger U, Rudà R, Minniti G, Garbossa D, Ius T. PMID: 42456530 [PubMed - as supplied by publisher]
	Factors Associated With Overall Survival and 90-Day Mortality Following Resection of Melanoma Brain Metastases. Oper Neurosurg Faraj CA, Hasanov M, Milton DR, Katlowitz KA, Srinivasan S, Suki D, Goethe EA, Prabhu SS, Ene CI, Weinberg JS, McCutcheon IE, Glitza Oliva IC, Ferguson SD. PMID: 42454898 [PubMed - indexed for MEDLINE]
	Recent Developments in the Diagnosis and Treatment of Disseminated and Rare Melanoma with Radiotheranostics. ACS Pharmacol Transl Sci Exner RM, Lewis JS, Bodei L, Pillarsetty NVK. PMID: 42453340 [PubMed]
	Real-World Treatment Outcomes After Nivolumab Progression in BRAF-Negative Metastatic Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group. J Clin Med Eniseler EB, Erdogan AP, , Keskin Uzundere F, , Gür HB, Hac, Balc, Beyp, Savsar MG, Pempe G, Oksuz S, Ba, Demirk, Demir B, Aç, Demiray AG, Akarca MS, Ünek , Kara M, Urun M, Gökay AC, Ye, Ekinci F. PMID: 42452684 [PubMed]
	MITF Is an Essential and Functionally Multifaceted Transcription Factor in Cutaneous Melanoma. Cancers (Basel) Ondru, Kreisingerová K, Vachtenheim J. PMID: 42449703 [PubMed]
	From Excision to Immunity: The Full Spectrum of Modern Melanoma Treatments. Cancers (Basel) Murugesan V, Thuraisingam T, Radzioch D. PMID: 42449588 [PubMed]
	Gene therapy for uveal melanoma. Clin Transl Oncol Bushra A, Irudayaraj J. PMID: 42446821 [PubMed - as supplied by publisher]
	Survival Nomogram for Stage IV (M1a-c) Melanoma: A Population-Based Study Highlighting the Prognostic Correlates of Surgery in Pre-Immunotherapy and Early Immunotherapy Eras. J Invest Surg Mo DC, Huang JF, Luo PH, Lin P, Huang SX, Wang HL, Liang XJ. PMID: 42446161 [PubMed - indexed for MEDLINE]
	Phenotypic and Dermoscopic Features in First-Degree Relatives of Melanoma Patients: A Controlled Cross-Sectional Study. Clin Cosmet Investig Dermatol Ünlü CI, Sar, Aydo, Bülbül Ba, Yazici S, Öztürk F, . PMID: 42445670 [PubMed]
	Non-Publication of Interventional Studies for Uveal Melanoma. Ocul Oncol Pathol Butt FR, Rahman S, Dhivagaran T, Tao BK, Parvand M, Gou D, Ing EB. PMID: 42445343 [PubMed - as supplied by publisher]
	Health system costs and systemic treatment patterns by disease stage for 8577 people diagnosed with melanoma in New South Wales, Australia 2006-2019. PLoS One Goldsbury DE, Cust AE, Watts C, Pearce A, Haywood P, Collins LG, Ngo P, McLoughlin K, Caruana M, Canfell K, Steinberg J, Weber MF. PMID: 42441625 [PubMed - indexed for MEDLINE]
	Reshaping the Battlefield: Reprogramming the Melanoma Tumour Microenvironment (TME) by Anti-CTLA-4, Anti-PD-1, and Anti-PD-L1 Monotherapy and Combination Therapy: A Systematic Review and Meta-Analysis of Preclinical and Clinical Evidence. Cells Karakousis VA, Mantalovas S, Karakousi VC, Vizirianakis IS, Papamitsou T, Pavlidis L, Kosmidis CS. PMID: 42439659 [PubMed - indexed for MEDLINE]
	Malignant melanoma of small intestine. Pol Merkur Lekarski Miku, Suder P, Augustyn M, Grys I, Kopp B. PMID: 42435477 [PubMed - indexed for MEDLINE]
	Ancillary Diagnostic Utility of Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) in Diagnostically Challenging Hepatic Angiomyolipoma. Cureus Kim S, Karzoun MZ, Zhou Y, Zhong M, Murugan P, Schat R, Ankeny J, Park BU. PMID: 42434639 [PubMed]

Articles 1 - 20 / 45993

Page 1 of 2300



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy